Immunoinformatics-aided rational design of multiepitope-based peptide vaccine (MEBV) targeting human parainfluenza virus 3 (HPIV-3) stable proteins.
Md Sakib HossenMd Nazmul HasanMunima HaqueTawsif Al ArianSajal Kumar HalderMd Jasim UddinM Abdullah-Al-MamunMd Salman ShakilPublished in: Journal, genetic engineering & biotechnology (2023)
The in silico designed HPIV-3 vaccine demonstrated potential in evoking an effective immune response. This study paves the way for further preclinical and clinical evaluation of the vaccine, offering hope for a future solution to combat HPIV-3 infections.